.................................................... รายการ ปี 25XX อัตราส่วนสภาพคล่อง (current ratio) (เท่า) ความสามารถในการชำระดอกเบี้ย (interest coverage ratio : ICR) (เท่า) หนี้สินที่มีภาระดอกเบี้ยต่อกำไรก่อนดอกเบี้ยจ่าย ภาษีเงินได้ ค่าเสื่อมราคาและค่า
(expense) Q1-2022 Q1-2023 THB Mn THB Mn THB Mn % Current tax on profit for the period (9.4) (10.8) 1.4 14.9% Deferred income tax (13.1) (1.3) (11.8) (90.1%) Tax expense (22.5) (12.1) (10.4) (46.2%) Change
in Q1 2024. The gain on foreign currency exchange in Q1 2024 was mainly associated with other current financial assets in USD related to the proceeds from sale of Sakthi auto component Limited (SACL
in new projects which in the process of development and construction. Tax income (expense) Tax income (expense) Quarter 1 Quarter 1 Change (Unit: THB Mn) 2023 2024 Amount % Current tax on profit for
(current ratio) (เท่า) ความสามารถในการชำระดอกเบี้ย (interest coverage ratio : ICR) (เท่า) หนี้สินที่มีภาระดอกเบี้ยต่อกำไรก่อนดอกเบี้ยจ่าย ภาษีเงินได้ ค่าเสื่อมราคาและ ค่าตัดจำหน่าย (interest bearing debt to
As at December 31, 2015 As at December 31, 2016 As at December 31, 2017 Statement of Financial Position Assets Current assets 781.90 434.67 948.25 Non-current assets 62,989.94 89,411.74 106,802.92
the outstanding balance of trade and other receivables, almost 89% of total net trade and other receivables, were under current due. Average collection period decreased from 76 days to 75 days
.06%, mainly due to decreasing of current investment in amount of Baht 15 .00 million (because it reached the maturity term and became 3-months deposit so it was classified as cash and cash equivalent
development improvement and equipment, cash and equivalents. More total liabilities which increase at amount Baht 26.85 million or 3.74%, as defaulted liabilities, Trade and other current payable, finance lease
32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine